with Jasvir Singh
Oxytocin therapy may help patients with chronic headaches, which is 3 percent of the U.S. population. There is no current effective treatment, so this would be a real breakthrough.
Trigemina Inc. is a start-up company that is examining new opportunities for treating pain. One of these new opportunities is intranasal oxytocin. They are conducting a study comparing intranasal oxytocin with placebo for treating debilitating, recurrent headaches.
There's just a bit more information in their press release.